{"id":41818,"date":"2018-09-19T11:00:54","date_gmt":"2018-09-19T02:00:54","guid":{"rendered":"http:\/\/www.veeva.com\/jp\/?p=41818"},"modified":"2018-09-19T16:11:20","modified_gmt":"2018-09-19T07:11:20","slug":"2018-veeva-rd-summit-to-showcase-advances-for-speeding-product-development","status":"publish","type":"post","link":"https:\/\/pantheon.veeva.com\/jp\/news\/2018-veeva-rd-summit-to-showcase-advances-for-speeding-product-development\/","title":{"rendered":"2018 Veeva R&#038;D Summit\u3092\u958b\u50ac\u3001\u88fd\u54c1\u958b\u767a\u306e\u8fc5\u901f\u5316\u3092\u6210\u529f\u3055\u305b\u305f\u6700\u65b0\u60c5\u5831\uff0f\u6226\u7565\u3092\u767a\u8868"},"content":{"rendered":"<p style=\"text-align: right;\">2018\u5e749\u670819\u65e5<\/p>\n<p style=\"text-align: right;\">Veeva Japan\u682a\u5f0f\u4f1a\u793e<\/p>\n<p>&nbsp;<\/p>\n<p>Veeva Systems\u3010NYSE:VEEV\u3011(\u672c\u793e : \u30ab\u30ea\u30d5\u30a9\u30eb\u30cb\u30a2\u5dde\u30d7\u30ec\u30b6\u30f3\u30c8\u30f3\u3001\u65e5\u672c\u6cd5\u4eba \u672c\u793e : \u6771\u4eac\u90fd\u6e0b\u8c37\u533a\u3001\u65e5\u672c\u6cd5\u4eba\u4ee3\u8868\u53d6\u7de0\u5f79 : \u5ca1\u6751 \u5d07\u3001\u4ee5\u4e0b Veeva)\u306f\u30019\u670816\u65e5\uff5e18\u65e5\u306b\u304b\u3051\u3066\u3001\u7c73\u56fd\u30d5\u30a3\u30e9\u30c7\u30eb\u30d5\u30a3\u30a2\u3067<strong><a href=\"https:\/\/www.veeva.com\/events\/rd-summit\/\">2018 Veeva R&amp;D Summit<\/a><\/strong>\u3092\u958b\u50ac\u3057\u307e\u3059\u3002\u3053\u306e\u30a4\u30d9\u30f3\u30c8\u3067\u306f\u30011,300\u4eba\u3092\u8d85\u3048\u308b\u30e9\u30a4\u30d5\u30b5\u30a4\u30a8\u30f3\u30b9\u306e\u30d7\u30ed\u30d5\u30a7\u30c3\u30b7\u30e7\u30ca\u30eb\u304a\u3088\u3073\u5c02\u9580\u5bb6\u306b\u304a\u96c6\u307e\u308a\u3044\u305f\u3060\u304d\u3001\u88fd\u54c1\u958b\u767a\u306e\u8fc5\u901f\u5316\u306b\u5411\u3051\u305f\u3001\u6700\u65b0\u60c5\u5831\u3092\u767a\u8868\u3057\u307e\u3059\u3002(\u672c\u30ea\u30ea\u30fc\u30b9\u306f\u3001Veeva\u7c73\u56fd\u672c\u793e\u304c\u767a\u8868\u3057\u305f\u5831\u9053\u8cc7\u6599\u306e\u6284\u8a33\u3067\u3059\u3002\u539f\u6587\u306f<strong><a href=\"https:\/\/www.veeva.com\/resources\/2018-veeva-rd-summit-to-showcase-advances-in-speeding-product-development\/\">\u3053\u3061\u3089<\/a><\/strong>\u304b\u3089\u304a\u8aad\u307f\u3044\u305f\u3060\u3051\u307e\u3059\u3002)<\/p>\n<p>&nbsp;<\/p>\n<p>\u3053\u306eSummit\u306f\u3001bluebird bio\u793e\u306e\u30c1\u30fc\u30d5\u30fb\u30d6\u30eb\u30fc\u30d0\u30fc\u30c9\u3067\u3042\u308bNick Leschly\u6c0f\u3068\u306e\u907a\u4f1d\u6027\u75be\u60a3\u304a\u3088\u3073\u5e0c\u5c11\u75be\u60a3\u306b\u304a\u3051\u308b\u753b\u671f\u7684\u306a\u30a4\u30ce\u30d9\u30fc\u30b7\u30e7\u30f3\u306e\u53ef\u80fd\u6027\u306b\u95a2\u3059\u308b\u30c7\u30a3\u30b9\u30ab\u30c3\u30b7\u30e7\u30f3\u3067\u5e55\u958b\u3051\u3057\u307e\u3059\u3002\u540c\u6c0f\u306f\u3001Veeva\u306e\u30d7\u30ec\u30b8\u30c7\u30f3\u30c8\u517c\u5171\u540c\u5275\u696d\u8005\u3067\u3042\u308bMatt Wallach\u3068\u5171\u306b\u300c\u907a\u4f1d\u5b50\u6cbb\u7642\u304c\u3082\u305f\u3089\u3059\u75be\u75c5\u6cbb\u7642\u306e\u5177\u73fe\u5316\u300d\u3068\u3044\u3046\u30c6\u30fc\u30de\u3067\u30d5\u30a1\u30a4\u30a2\u30fc\u30b5\u30a4\u30c9\u30fb\u30c1\u30e3\u30c3\u30c8\u306b\u81e8\u5e2d\u3057\u307e\u3059\u3002<\/p>\n<p>100\u4eba\u3092\u8d85\u3048\u308b\u3001\u88fd\u85ac\u3001\u30d0\u30a4\u30aa\u30c6\u30c3\u30af\u304a\u3088\u3073\u533b\u7642\u6a5f\u5668\u306e\u5206\u91ce\u306b\u304a\u3051\u308b\u4e00\u6d41\u306e\u30d7\u30ed\u30d5\u30a7\u30c3\u30b7\u30e7\u30ca\u30eb\u304c\u3001\u81e8\u5e8a\u958b\u767a\u3001\u85ac\u4e8b\u304a\u3088\u3073\u54c1\u8cea\u7ba1\u7406\u306e\u5404\u696d\u52d9\u306b\u304a\u3051\u308b\u88fd\u54c1\u958b\u767a\u30d7\u30ed\u30bb\u30b9\u306e\u52b9\u7387\u5316\u306b\u5411\u3051\u305f\u8a73\u7d30\u306a\u30d9\u30b9\u30c8\u30d7\u30e9\u30af\u30c6\u30a3\u30b9\u3092\u5171\u6709\u3057\u307e\u3059\u3002\u4eca\u5e74\u306e\u30a4\u30d9\u30f3\u30c8\u3067\u306f\u7279\u306b\u3001\u81e8\u5e8a\u8a66\u9a13\u30d1\u30d5\u30a9\u30fc\u30de\u30f3\u30b9\u306e\u6700\u9069\u5316\u3001\u81e8\u5e8a\u30c7\u30fc\u30bf\u30de\u30cd\u30b8\u30e1\u30f3\u30c8\u306e\u518d\u69cb\u7bc9\u3001\u54c1\u8cea\u30de\u30cd\u30b8\u30e1\u30f3\u30c8\u306e\u8fd1\u4ee3\u5316\u304a\u3088\u3073\u85ac\u4e8b\u696d\u52d9\u306e\u5909\u9769\u306b\u95a2\u3057\u3066\u3001\u4e0b\u8a18\u306e\u3088\u3046\u306a\u57fa\u8abf\u8b1b\u6f14\u3092\u7528\u610f\u3057\u3066\u3044\u307e\u3059\u3002<\/p>\n<ul>\n<li><strong>Janssen Pharmaceuticals<\/strong><strong>\u793e\u3001<\/strong><strong>Pharmaceutical Product Development LLC<\/strong><strong>\uff08<\/strong><strong>PPD<\/strong><strong>\u793e\uff09\u304a\u3088\u3073<\/strong><strong>IACT Health<\/strong><strong>\u793e<\/strong>\u306f\u3001\u6cbb\u9a13\u4f9d\u983c\u8005\u3001\u533b\u85ac\u54c1\u958b\u767a\u696d\u52d9\u53d7\u8a17\u6a5f\u95a2\uff08CRO\uff09\u304a\u3088\u3073\u8a66\u9a13\u5b9f\u65bd\u533b\u7642\u6a5f\u95a2\u304c\u3001\u3088\u308a\u9069\u5207\u306b\u5354\u529b\u3057\u306a\u304c\u3089\u81e8\u5e8a\u8a66\u9a13\u3092\u5b9f\u65bd\u3059\u308b\u305f\u3081\u306e\u3001\u81e8\u5e8a\u8a66\u9a13\u60c5\u5831\u306e\u5171\u6709\u3092\u6539\u5584\u3059\u308b\u5951\u6a5f\u3092\u660e\u3089\u304b\u306b\u3057\u307e\u3059\u3002<\/li>\n<li><strong>Cara Therapeutics<\/strong><strong>\u793e<\/strong>\u306f\u3001\u6700\u65b0\u306eEDC\u30bd\u30ea\u30e5\u30fc\u30b7\u30e7\u30f3\u306b\u3088\u308a\u3001\u3069\u306e\u3088\u3046\u306b\u81e8\u5e8a\u30c7\u30fc\u30bf\u30de\u30cd\u30b8\u30e1\u30f3\u30c8\u3092\u6539\u5584\u3057\u3001\u81e8\u5e8a\u8a66\u9a13\u30c7\u30fc\u30bf\u30d9\u30fc\u30b9\u306e\u69cb\u7bc9\u3068\u8a2d\u8a08\u3092\u8fc5\u901f\u5316\u3057\u305f\u304b\u3092\u8aac\u660e\u3057\u307e\u3059\u3002<\/li>\n<li><strong>Bristol-Myers Squibb<\/strong><strong>\u793e<\/strong>\u306f\u3001\u4f01\u696d\u5168\u4f53\u306e\u6226\u7565\u7684\u306a\u53d6\u308a\u7d44\u307f\u306b\u3088\u308a\u3001\u54c1\u8cea\u30de\u30cd\u30b8\u30e1\u30f3\u30c8\u3092\u30b0\u30ed\u30fc\u30d0\u30eb\u3067\u8fd1\u4ee3\u5316\u3057\u3001\u5909\u66f4\u7ba1\u7406\u30d7\u30ed\u30bb\u30b9\u3092\u5909\u9769\u3059\u308b\u305f\u3081\u306e\u30d3\u30b8\u30e7\u30f3\u3092\u5171\u6709\u3057\u307e\u3059\u3002<\/li>\n<li><strong>Eli Lilly and Company<\/strong><strong>\u793e<\/strong>\u306f\u3001RIM\u306e\u5909\u9769\u306b\u5411\u3051\u305f\u9769\u65b0\u7684\u306a\u30a2\u30d7\u30ed\u30fc\u30c1\u3068\u3001\u5358\u4e00\u306eRIM\u30d7\u30e9\u30c3\u30c8\u30d5\u30a9\u30fc\u30e0\u4e0a\u3067\u306e\u627f\u8a8d\u5f8c\u306e\u5909\u66f4\u306b\u304a\u3051\u308b\u3001\u30a8\u30f3\u30c9\u30c4\u30fc\u30a8\u30f3\u30c9\u30d7\u30ed\u30bb\u30b9\u306e\u5b9f\u73fe\u306b\u3064\u3044\u3066\u8b1b\u6f14\u3057\u307e\u3059\u3002<\/li>\n<\/ul>\n<p>Veeva\u306eCEO\u517c\u5275\u8a2d\u8005\u3067\u3042\u308bPeter Gassner\u306f\u57fa\u8abf\u8b1b\u6f14\u3067\u3001Veeva Vault\u304c\u81e8\u5e8a\u958b\u767a\u3001\u85ac\u4e8b\u3001\u54c1\u8cea\u7ba1\u7406\uff08\u8fd1\u65e5\u4e2d\u306b\u306f\u5b89\u5168\u6027\u3082\uff09\u306e\u5404\u696d\u52d9\u306b\u304a\u3044\u3066\u3001\u696d\u754c\u306e\u88fd\u54c1\u958b\u767a\u30d7\u30ed\u30bb\u30b9\u306e\u5909\u9769\u3092\u3069\u306e\u3088\u3046\u306b\u5b9f\u73fe\u3057\u3066\u3044\u308b\u306e\u304b\u3001\u3054\u8aac\u660e\u3057\u307e\u3059\u3002\u307e\u305f\u3001\u81e8\u5e8a\u8a66\u9a13\u4e2d\u306b\u3001\u6cbb\u9a13\u4f9d\u983c\u8005\u3001CRO\u304a\u3088\u3073\u8a66\u9a13\u5b9f\u65bd\u533b\u7642\u6a5f\u95a2\u304c\u30b7\u30fc\u30e0\u30ec\u30b9\u306b\u5354\u696d\u3059\u308b\u306e\u3092\u30b5\u30dd\u30fc\u30c8\u3059\u308bVeeva\u306e\u30d3\u30b8\u30e7\u30f3\u3082\u660e\u3089\u304b\u306b\u3057\u307e\u3059\u3002Veeva Vault\u62c5\u5f53\u30b7\u30cb\u30a2\u30f4\u30a1\u30a4\u30b9\u30d7\u30ec\u30b8\u30c7\u30f3\u30c8\u306eJen Goldsmith\u304a\u3088\u3073Veeva Vault\u62c5\u5f53\u30bc\u30cd\u30e9\u30eb\u30de\u30cd\u30fc\u30b8\u30e3\u30fc\u306eAvril England\u306f\u3001<strong><a href=\"https:\/\/www.veeva.com\/jp\/products\/development-cloud\/\">Veeva Development Cloud<\/a><\/strong>\u3067\u30b0\u30ed\u30fc\u30d0\u30eb\u306b\u3001\u7814\u7a76\u3068\u958b\u767a\u5168\u4f53\u306b\u304a\u3051\u308b\u30d0\u30ea\u30a8\u30fc\u30b7\u30e7\u30f3\u30de\u30cd\u30b8\u30e1\u30f3\u30c8\u3084\u5909\u66f4\u7ba1\u7406\u306a\u3069\u3092\u30a8\u30f3\u30c9\u30c4\u30fc\u30a8\u30f3\u30c9\u306b\u30d7\u30ed\u30bb\u30b9\u7ba1\u7406\u3059\u308b\u65b9\u6cd5\u306b\u3064\u3044\u3066\u7d39\u4ecb\u3057\u307e\u3059\u3002<\/p>\n<p>60\u3092\u8d85\u3048\u308b\u30bb\u30c3\u30b7\u30e7\u30f3\u3068\u30ef\u30fc\u30af\u30b7\u30e7\u30c3\u30d7\u306b\u306f\u3001\u6b21\u306e\u5404\u793e\u304b\u3089\u8b1b\u6f14\u8005\u3092\u304a\u8fce\u3048\u3057\u307e\u3059\u3002AbbVie\u3001Agios Pharmaceuticals\u3001Alkermes PLC\u3001Allakos\u3001Atlantic Research Group\u3001BioEnterprise\u3001Clintec\u3001Gilead Sciences, Inc.\u3001GlaxoSmithKline\u3001ICON plc\u3001Incyte Corporation\u3001Integra LifeSciences\u3001Intersect ENT\u3001Ionis Pharmaceuticals, Inc.\u3001Melinta Therapeutics Inc.\u3001Ora, Inc.\u3001Radius Health\u3001Regeneron Pharmaceuticals Inc.\u3001Replimune Group Inc.\u3001Seattle Genetics, Inc.\u3001Syneos Health\u3001Sysmex Corporation\u3001TESARO, Inc.\u3001Ultragenyx Pharmaceutical Inc.\u3001Upsher-Smith Laboratories LLC\u4ed6<\/p>\n<p>2018 Veeva R&amp;D Summit\u306e\u30b9\u30dd\u30f3\u30b5\u30fc\u306f\u3001\u6b21\u306e\u5404\u793e\u3067\u3059\u3002Accenture\u3001AG Mednet\u3001Amazon Web Services\u3001C3i Solutions\u3001CGI\u3001Cognizant\u3001Comprehend Systems, Inc.\u3001Deloitte\u3001EY\u3001FME\u3001Ideagen Plc\u3001LPW Training Services\u3001Mavens\u3001NNIT\u3001Qlik\u3001SDL\u3001Tata Consultancy Services\u3001Trifecta\u3001UL PURE Learning\u3001Valiance Partners<\/p>\n<p>Veeva R&amp;D Summit\u306f\u3001Veeva\u306e\u304a\u5ba2\u69d8\u304a\u3088\u3073\u3054\u62db\u5f85\u5ba2\u306e\u7686\u69d8\u5411\u3051\u306e\u7121\u6599\u306e\u30a4\u30d9\u30f3\u30c8\u3067\u3059\u3002\u8a73\u7d30\u60c5\u5831\u304a\u3088\u3073\u30a2\u30b8\u30a7\u30f3\u30c0\u5168\u4f53\u306e\u8a73\u7d30\u306f\u3001<strong><a href=\"https:\/\/www.veeva.com\/events\/rd-summit\/\">veeva.com\/R&amp;DSummit<\/a><\/strong>\u3092\u3054\u89a7\u304f\u3060\u3055\u3044\u3002<br \/>\n&nbsp;<\/p>\n<p><strong>\u3010Veeva Systems\u793e\u306b\u3064\u3044\u3066\u3011<br \/>\n<\/strong>Veeva Systems\u793e\u306f\u30b0\u30ed\u30fc\u30d0\u30eb\u306a\u30e9\u30a4\u30d5\u30b5\u30a4\u30a8\u30f3\u30b9\u4f01\u696d\u3084\u305d\u306e\u4ed6\u306e\u898f\u5236\u3092\u53d7\u3051\u308b\u88fd\u9020\u696d\u8005\u5411\u3051\u306b\u3001\u30af\u30e9\u30a6\u30c9\u30d9\u30fc\u30b9\u306e\u30bd\u30d5\u30c8\u30a6\u30a7\u30a2\u3092\u63d0\u4f9b\u3059\u308b\u30ea\u30fc\u30c7\u30a3\u30f3\u30b0\u30ab\u30f3\u30d1\u30cb\u30fc\u3067\u3059\u3002\u4e16\u754c\u6700\u5927\u898f\u6a21\u306e\u88fd\u85ac\u4f1a\u793e\u304b\u3089\u30d0\u30a4\u30aa\u30c6\u30af\u30ce\u30ed\u30b8\u30fc\u5206\u91ce\u306e\u65b0\u8208\u4f01\u696d\u307e\u3067650\u793e\u3092\u8d85\u3048\u308b\u9867\u5ba2\u3092\u64c1\u3057\u3001\u6280\u8853\u9769\u65b0\u3078\u306e\u53d6\u308a\u7d44\u307f\u3084\u5353\u8d8a\u3057\u305f\u88fd\u54c1\u529b\u306b\u3088\u3063\u3066\u3001\u304a\u5ba2\u69d8\u306e\u6210\u529f\u3092\u30b5\u30dd\u30fc\u30c8\u3057\u3066\u3044\u307e\u3059\u3002Veeva\u306f\u3001\u30b5\u30f3\u30d5\u30e9\u30f3\u30b7\u30b9\u30b3\u306e\u30d9\u30a4\u30a8\u30ea\u30a2\u306b\u672c\u793e\u3092\u7f6e\u304d\u3001\u30e8\u30fc\u30ed\u30c3\u30d1\u3001\u30a2\u30b8\u30a2\u3001\u30e9\u30c6\u30f3\u30a2\u30e1\u30ea\u30ab\u306b\u62e0\u70b9\u3092\u5c55\u958b\u3057\u3066\u3044\u307e\u3059\u3002\u8a73\u3057\u304f\u306f\u3001<strong><a href=\"https:\/\/veeva.com\/jp\/\" target=\"_blank\" rel=\"noopener noreferrer\">\u516c\u5f0f\u30b5\u30a4\u30c8<\/a><\/strong>\u3092\u3054\u89a7\u304f\u3060\u3055\u3044\u3002<\/p>\n<p><strong>\u3010Forward-looking Statements\u3011<\/strong><br \/>\nThis release contains forward-looking statements, including the market demand for and acceptance of Veeva\u2019s products and services, the results from use of Veeva\u2019s products and services, and general business conditions, particularly in the life sciences industry. Any forward-looking statements contained in this press release are based upon Veeva\u2019s historical performance and its current plans, estimates, and expectations, and are not a representation that such plans, estimates, or expectations will be achieved. These forward-looking statements represent Veeva\u2019s expectations as of the date of this press announcement. Subsequent events may cause these expectations to change, and Veeva disclaims any obligation to update the forward-looking statements in the future. These forward-looking statements are subject to known and unknown risks and uncertainties that may cause actual results to differ materially. Additional risks and uncertainties that could affect Veeva\u2019s financial results are included under the captions, \u201cRisk Factors\u201d and \u201cManagement\u2019s Discussion and Analysis of Financial Condition and Results of Operations,\u201d in the company\u2019s filing on Form 10-Q for the period ended April\u00a030, 2018. This is available on the company\u2019s website at <a href=\"https:\/\/www.veeva.com\/\">www.veeva.com<\/a> under the Investors section and on the SEC\u2019s website at <a href=\"http:\/\/www.sec.gov\/\">www.sec.gov<\/a>. Further information on potential risks that could affect actual results will be included in other filings Veeva makes with the SEC from time to time.<\/p>\n","protected":false},"excerpt":{"rendered":"<p>2018\u5e749\u670819\u65e5 Veeva Japan\u682a\u5f0f\u4f1a\u793e &nbsp; Veeva Systems\u3010NYSE:VEEV\u3011(\u672c\u793e : \u30ab\u30ea\u30d5\u30a9\u30eb\u30cb\u30a2\u5dde\u30d7\u30ec\u30b6\u30f3\u30c8\u30f3\u3001\u65e5\u672c\u6cd5\u4eba \u672c\u793e : \u6771\u4eac\u90fd\u6e0b\u8c37\u533a\u3001\u65e5\u672c\u6cd5\u4eba\u4ee3\u8868\u53d6\u7de0\u5f79 : \u5ca1\u6751&hellip;<\/p>\n","protected":false},"author":131,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[322],"tags":[],"class_list":["post-41818","post","type-post","status-publish","format-standard","hentry","category-press-release","blog-product-veeva-rd"],"acf":[],"aioseo_notices":[],"_links":{"self":[{"href":"https:\/\/pantheon.veeva.com\/jp\/wp-json\/wp\/v2\/posts\/41818"}],"collection":[{"href":"https:\/\/pantheon.veeva.com\/jp\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/pantheon.veeva.com\/jp\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/pantheon.veeva.com\/jp\/wp-json\/wp\/v2\/users\/131"}],"replies":[{"embeddable":true,"href":"https:\/\/pantheon.veeva.com\/jp\/wp-json\/wp\/v2\/comments?post=41818"}],"version-history":[{"count":4,"href":"https:\/\/pantheon.veeva.com\/jp\/wp-json\/wp\/v2\/posts\/41818\/revisions"}],"predecessor-version":[{"id":41826,"href":"https:\/\/pantheon.veeva.com\/jp\/wp-json\/wp\/v2\/posts\/41818\/revisions\/41826"}],"wp:attachment":[{"href":"https:\/\/pantheon.veeva.com\/jp\/wp-json\/wp\/v2\/media?parent=41818"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/pantheon.veeva.com\/jp\/wp-json\/wp\/v2\/categories?post=41818"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/pantheon.veeva.com\/jp\/wp-json\/wp\/v2\/tags?post=41818"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}